...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of voice: official journal of the Voice Foundation >Glucocorticoids for vocal fold disease: A survey of otolaryngologists
【24h】

Glucocorticoids for vocal fold disease: A survey of otolaryngologists

机译：声带疾病的糖皮质激素：耳鼻喉科医生的调查

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective/Hypothesis: Glucocorticoids (GCs) are commonly used in the treatment of laryngeal disorders despite the absence of clear guidelines regarding their use. We sought to assess clinical practice patterns regarding GC use for various vocal fold diseases and to ascertain factors underlying the selection of particular GCs for different vocal fold pathology. Study Design: Prospective, survey. Methods: A web-based 20-question survey querying clinical indications for GC use and other factors influencing decision making in GC administration was distributed to 5280 otolaryngologists via e-mail using a commercially available database. Results: The overall response rate for the survey was 4% (212/5280). Of the respondents, 99% reported GCs to be valuable in their practice. Previous experience/results, familiarity, and use in practice (68%, 54%, and 37%, respectively) were the most commonly cited reasons for choosing a particular GC; pharmacokinetic profile and academic literature were infrequently cited reasons. Fifty-four percent of respondents were more likely to prescribe GCs for vocal performers compared with other patients. Additionally, most respondents stated that the potential for side effects only occasionally prevented GC utilization. Conclusions: GC prescription practices vary greatly among otolaryngologists. Drug choice appears to be driven primarily by clinician preference and personal experience rather than by specific pharmacologic or physiologic rationale. These findings likely reflect the current lack of well-constructed studies in the laryngology literature to guide GC selection and administration for benign disorders of the larynx and highlight an important potential area for future studies.
机译：目的/假设：尽管没有关于其使用的明确指导，但糖皮质激素通常用于治疗喉障碍。我们试图评估关于各种声带疾病的GC使用的临床实践模式，并确定不同声音折叠病理学选择特定GCS的因素。研究设计：预期，调查。方法：通过通过电子邮件使用商业上可获得的数据库将基于Web的20个20质量调查查询查询GC使用的临床适应症和影响GC局部决策的因素分发到5280个耳鼻喉科医生。结果：调查的整体响应率为4％（212/5280）。受访者，99％报告的GCS在其实践中是有价值的。以前的经验/结果，熟悉和在实践中使用（分别为68％，54％和37％）是选择特定GC的最常用原因;药代动力学概况和学术文献是不经常引用的原因。与其他患者相比，54％的受访者更有可能为声带表演者开门。此外，大多数受访者表示，只有偶尔的副作用可能阻止GC利用率。结论：GC处方实践在耳鼻喉科医生之间有很大差异。药物选择似乎主要由临床医生偏好和个人体验而不是特定的药理学或生理学理由驱动。这些调查结果可能反映了目前喉科文学中缺乏建设的良好研究，以指导喉部良好疾病的GC选择和管理，并突出了未来研究的重要潜在领域。

著录项

  • 来源
  • 作者

    GovilN.; RafiiB.Y.; PaulB.C.; RuizR.; AminM.R.; BranskiR.C.;

  • 作者单位

    NYU Voice Center Department of Otolaryngology-Head and Neck Surgery New York University School of;

    NYU Voice Center Department of Otolaryngology-Head and Neck Surgery New York University School of;

    NYU Voice Center Department of Otolaryngology-Head and Neck Surgery New York University School of;

    NYU Voice Center Department of Otolaryngology-Head and Neck Surgery New York University School of;

    NYU Voice Center Department of Otolaryngology-Head and Neck Surgery New York University School of;

    NYU Voice Center Department of Otolaryngology-Head and Neck Surgery New York University School of;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 喉科学、喉疾病;
  • 关键词

    Dysphonia; Glucocorticoid; Steroid; Voice;

    机译：呼吸困难;糖皮质激素;类固醇;声音;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号